Free Trial
NASDAQ:IMAC

IMAC (IMAC) Stock Price, News & Analysis

$2.81
+0.37 (+15.16%)
(As of 06/12/2024 ET)
Today's Range
$2.37
$3.33
50-Day Range
$2.51
$5.10
52-Week Range
$0.75
$1.65
Volume
288,504 shs
Average Volume
708,132 shs
Market Capitalization
$74.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
IMAC stock logo

About IMAC Stock (NASDAQ:IMAC)

IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.

IMAC Stock Price History

IMAC Stock News Headlines

See More Headlines
Receive IMAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/14/2022
Today
6/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Specialty Outpatient Clinics
Sub-Industry
N/A
Current Symbol
NASDAQ:IMAC
Fax
N/A
Employees
106
Year Founded
N/A

Profitability

Net Income
$-10,540,000.00
Pretax Margin
-75.40%

Debt

Sales & Book Value

Annual Sales
$15.22 million
Book Value
$0.69 per share

Miscellaneous

Free Float
23,837,000
Market Cap
$74.42 million
Optionable
Not Optionable
Beta
-0.88
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Jeffrey S. Ervin M.B.A. (Age 44)
    Chairman & CEO
    Comp: $377.69k
  • Dr. Matthew C. WallisDr. Matthew C. Wallis (Age 48)
    Pres & Exec. Director
    Comp: $289.83k
  • Ms. Sheri F. Gardzina CPA (Age 53)
    CPA, CFO & Corp. Sec.
    Comp: $254.82k
  • Dr. Ben Lerner (Age 55)
    Chief Operating Officer
  • Mr. Frank DeVito III
    Director of Sales
  • Ms. Norleidy Hernandez
    HR Director
  • Mr. Sandy Miller
    Chief of Staff

IMAC Stock Analysis - Frequently Asked Questions

How have IMAC shares performed in 2024?

IMAC's stock was trading at $2.21 at the beginning of 2024. Since then, IMAC stock has increased by 27.1% and is now trading at $2.81.
View the best growth stocks for 2024 here
.

How were IMAC's earnings last quarter?

IMAC Holdings, Inc. (NASDAQ:IMAC) issued its earnings results on Thursday, April, 14th. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.09) by $0.03. IMAC had a negative trailing twelve-month return on equity of 52.17% and a negative net margin of 75.40%.

What other stocks do shareholders of IMAC own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IMAC investors own include VBI Vaccines (VBIV), Biocept (BIOC), Energy Transfer (ET), iBio (IBIO), McEwen Mining (MUX), OPKO Health (OPK), Advanced Micro Devices (AMD), Amarin (AMRN), Aytu BioPharma (AYTU) and Bionano Genomics (BNGO).

When did IMAC IPO?

IMAC (IMAC) raised $4 million in an IPO on the week of February 11th 2019. The company issued 900,000 shares at $5.00 per share. Dawson James Securities and Cuttone served as the underwriters for the IPO.

How do I buy shares of IMAC?

Shares of IMAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:IMAC) was last updated on 6/13/2024 by MarketBeat.com Staff

From Our Partners